Search
NovaBay Pharmaceuticals Inc
NBYAdd to Watchlist
1.950USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
68.61MMarket Cap
LossP/E TTM
NovaBay Pharmaceuticals Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-3.80
69.99%
Analyst Rating
2025-10-19
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of NovaBay Pharmaceuticals Inc?
According to NovaBay Pharmaceuticals Inc's FY2025 earnings report, its current assets were 8.68M, with a year-on-year change of 348.32.
What are the total assets of NovaBay Pharmaceuticals Inc?
According to NovaBay Pharmaceuticals Inc's FY2025 earnings report, its total assets of NovaBay Pharmaceuticals Inc were 9.04M, with a year-on-year change of 163.95.
What are the total liabilities of NovaBay Pharmaceuticals Inc?
According to NovaBay Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of NovaBay Pharmaceuticals Inc were 31.86M, with a year-on-year change of 796.99.
What is the total equity of NovaBay Pharmaceuticals Inc?
According to NovaBay Pharmaceuticals Inc's FY2025 earnings report, its total equity of NovaBay Pharmaceuticals Inc was -22.83M, with a year-on-year change of -17594.57.
What is the net financing of NovaBay Pharmaceuticals Inc?
According to NovaBay Pharmaceuticals Inc's FY2025 earnings report, its net financing of NovaBay Pharmaceuticals Inc was 4.62M, with a year-on-year change of 207.87.
What is the Earnings Per Share (EPS) of NovaBay Pharmaceuticals Inc?
According to NovaBay Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.80, with a year-on-year change of 69.99.
What is the debt-to-asset ratio of NovaBay Pharmaceuticals Inc?
According to NovaBay Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 0.74, with a year-on-year change of -95.51.
What is the Return on Assets (ROA) of NovaBay Pharmaceuticals Inc?
According to NovaBay Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -533.34, with a year-on-year change of -279.65.
What is the operating profit of NovaBay Pharmaceuticals Inc?
According to NovaBay Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -7.58M, with a year-on-year change of -2.79.